Concepedia

Hua‐Jay J. Cherng

HJ

7

Publications

144

Citations

7

H-Index

2020

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Columbia University Irving Medical Center

Hua‐Jay J. Cherng is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2020–2024

7

Publications

7

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

Hua‐Jay J. Cherng, Ryan Sun, Bryant Sugg et al. · Blood · 2022 · 50 citations · Full text

, , +20

Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib

Paul J. Hampel, Hua‐Jay J. Cherng, Timothy G. Call et al. · Blood Advances · 2020 · 22 citations · Full text

, , +9

Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy

Paolo Strati, Andrew Jallouk, Ryan Sun et al. · Leukemia · 2022 · 17 citations · Full text

, , +11

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Hua‐Jay J. Cherng, Stefan Alig, Yasuhiro Oki et al. · Blood Advances · 2022 · 15 citations · Full text

Combined Pirtobrutinib, Venetoclax, and Obinutuzumab As First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan et al. · Blood · 2024 · 14 citations · Full text

Rows per page

1–5 of 7